Exploring Methysergide. To explore a different substance…

Names:
UML-491
Methysergide
Sansert
N-(1-Hydroxybutan-2-yl)-1-methyllysergamide
IUPAC name:
(8β)-N-(1-Hydroxybutan-2-yl)-1,6-dimethyl-9,10-didehydroergoline-8-carboxamide
5340 · C21H27N3O2 · 353.458
InChI=1S/C21H27N3O2/c1-4-15(12-25)22-21(26)14-8-17-16-6-5-7-18-20(16)13(10-23(18)2)9-19(17)24(3)11-14/h5-8,10,14-15,19,25H,4,9,11-12H2,1-3H3,(H,22,26)/t14-,15?,19-/m1/s1
KPJZHOPZRAFDTN-NQUBZZJWSA-N This stereoisomer Any stereoisomer
CCC(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO

Meyers, FH; Rose, AJ; Smith, DE. Incidents involving the Haight-Ashbury population and some uncommonly used drugs. J. Psychedelic Drugs, 1 Apr 1968, 1 (2), 139–146. 842 kB. https://doi.org/10.1080/02791072.1968.10524531

Clarke, EGC. The identification of some proscribed psychedelic drugs. J. Forensic Sci. Soc., 1 Jan 1967, 7 (1), 46-50. 336 kB. https://doi.org/10.1016/S0015-7368(67)70370-9

Helm, K. Synthese und funktionelle In-vitro-Pharmakologie neuer Liganden des 5-HT2A-Rezeptors aus der Klasse. Ph. D. Thesis, Universität Regensburg, Dresden, 1 Jan 2014. 3.2 MB. #34

Jakubczyk, D; Cheng, JZ; O'Connor, SE. Biosynthesis of the ergot alkaloids. Nat. Prod. Rep., 28 Aug 2014, 31 (10), 1328-1338. 476 kB. https://doi.org/10.1039/C4NP00062E

Shulgin, AT. Basic Pharmacology and Effects. In Hallucinogens. A Forensic Drug Handbook; Laing, R; Siegel, JA, Eds., Academic Press, London, 2003; pp 67–137. 6.3 MB.

Jacob, P; Shulgin, AT. Structure-activity relationships of the classic hallucinogens and their analogs. In Hallucinogens: An update. NIDA Research Monograph 146; Lin, GC; Glennon, RA, Eds., U.S. Department of Health and Human Services, National Institute of Health, U.S. Government Printing Office, Washington, DC, 1994; pp 74–91. 51 kB.

Shulgin, AT. Chemistry of psychotomimetics. In Handbook of Experimental Pharmacology. Psychotropic Agents, Part III: Alcohol and Psychotomimetics, Psychotropic Effects of Central Acting Drugs; Hoffmeister, F; Stille, G, Eds., Springer-Verlag, Berlin, 1982; Vol. 55 (3), pp 3–29. 29.7 MB. #8l

Friedman, AP. Clinical observations with 1-methyl-lysergic acid butanolamide (UML-491) in vascular headache. Angiology, 1 Aug 1960, 11 (4), 364–366. 259 kB. https://doi.org/10.1177/000331976001100409 #UML-491

Shulgin, AT. Psychotomimetic agents. In Psychopharmacological Agents; Gordon, M, Ed., Academic Press, New York, 1976; Vol. 4, pp 59–146. 3.1 MB. #V

Nichols, DE. Potential psychotomimetics: Bromomethoxyamphetamines and structural congeners of lysergic acid. Ph. D. Thesis, University of Iowa, Iowa City, IA, 1 May 1973. 13.0 MB. #5

1-Hydroxymethyl-LSD
LA-MeO
23 October 2018 · Creative Commons BY-NC-SA ·